Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Repositioning metformin for cancer prevention and treatment
Brendan J. Quinn
, Hiroshi Kitagawa
, Regan M. Memmott
, Joell J. Gills
, Phillip A. Dennis
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
190
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Repositioning metformin for cancer prevention and treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Anticarcinogen
11%
Bioavailability
11%
Cancer Prevention
100%
Cancer Risk
11%
Cancer Therapy
100%
Clinical Trial
11%
Diabetes Mellitus
11%
Glycon
100%
Heredity
11%
Malignant Neoplasm
33%
Maturity Onset Diabetes of the Young
11%
Retrospective Study
11%
Type 2 Diabetes
11%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
11%
Bioavailability
11%
Clinical Trial
11%
Diabetes Mellitus
11%
Malignant Neoplasm
100%
Metformin
100%
Non Insulin Dependent Diabetes Mellitus
11%
Retrospective Study
11%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Clinical Trial
50%
Genetic Determinism
50%
Retrospective Study
50%
Keyphrases
Bioavailability Factor
11%